4462.: INOVA4Health – Translational Medicine Program (IBET, CEDOC/FCM, IPOLFG and ITQB) (Q2878446): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 40.0 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||
| 2,173,683.2 Euro
| ||||||||||
| Property / priority axis | |||||||||||
| Property / priority axis: Strengthening research, technological development and innovation / rank | |||||||||||
Normal rank | |||||||||||
| Property / co-financing rate | |||||||||||
40.0 percent
| |||||||||||
| Property / co-financing rate: 40.0 percent / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 17:36, 4 November 2022
Project Q2878446 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | 4462.: INOVA4Health – Translational Medicine Program (IBET, CEDOC/FCM, IPOLFG and ITQB) |
Project Q2878446 in Portugal |
Statements
2,173,683.2 Euro
0 references
5,434,208.0 Euro
0 references
40.0 percent
0 references
1 January 2015
0 references
31 December 2018
0 references
INSTITUTO DE BIOLOGIA EXPERIMENTAL E TECNOLÓGICA (IBET)
0 references
Q2993199 (Deleted Item)
0 references
Identifiers
LISBOA-01-0145-FEDER-007344
0 references